Limiting Myocardial Damage during Acute Myocardial Infarction by Inhibiting C-Reactive Protein
- 3 August 2006
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 355 (5) , 513-515
- https://doi.org/10.1056/nejmcibr063197
Abstract
A recent study in a rat model of coronary-artery occlusion shows that pretreatment with 1,6-bis(phosphocholine)-hexane inhibits increased myocardial damage that results from human C-reactive protein.Keywords
This publication has 4 references indexed in Scilit:
- Targeting C-reactive protein for the treatment of cardiovascular diseaseNature, 2006
- Early Inflammation and Risk of Long-Term Development of Heart Failure and Mortality in Survivors of Acute Myocardial InfarctionJournal of the American College of Cardiology, 2006
- C-Reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial InfarctionThe Journal of Experimental Medicine, 1999
- C-Reactive Protein Colocalizes With Complement in Human Hearts During Acute Myocardial InfarctionCirculation, 1997